Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid injection in cardiac surgery with cardiopulmonary bypass
CTR20160020Phase 3Active
- Sponsor
- Hunan Dongting Pharmaceutical
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in Cardiac valve disease (VHD), sponsored by Hunan Dongting Pharmaceutical. Started Jan 2016; status: active.
02
Drugs
tranexamic acid
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on CTR20160020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160020.